Search by Drug Name or NDC

NDC 68788-9559-01 Ondansetron 8 mg/1 Details

Ondansetron 8 mg/1

Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is ONDANSETRON.

MedlinePlus Drug Summary

Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Related Packages: 68788-9559-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ondansetron

Product Information

NDC	68788-9559
Product ID	68788-9559_e5770a0f-473d-421b-a041-3624554a55b0
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Ondansetron
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ondansetron
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Active Ingredient Strength	8
Active Ingredient Units	mg/1
Substance Name	ONDANSETRON
Labeler Name	Preferred Pharmaceuticals, Inc.
Pharmaceutical Class	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090469
Listing Certified Through	2024-12-31

Package

NDC 68788-9559-01 (68788955901)

Pricing Information	N/A
NDC Package Code	68788-9559-1
Billing NDC	68788955901
Package	10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (68788-9559-1)
Marketing Start Date	2013-08-27
NDC Exclude Flag	N